Related references
Note: Only part of the references are listed.Unconjugated PLGA nanoparticles attenuate temperature-dependent β-amyloid aggregation and protect neurons against toxicity: implications for Alzheimer's disease pathology
Pallabi Sil Paul et al.
JOURNAL OF NANOBIOTECHNOLOGY (2022)
Lysosomal dysfunction in neurodegeneration: emerging concepts and methods
Vinod Udayar et al.
TRENDS IN NEUROSCIENCES (2022)
Advances on erythrocyte-mimicking nanovehicles to overcome barriers in biological microenvironments
Flavia Castro et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN)
Claudia Pina Costa et al.
PHARMACEUTICALS (2021)
Engineering precision nanoparticles for drug delivery
Michael J. Mitchell et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
Ruben G. R. Pinheiro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders (Dec, 10.1038/s41380-020-00999-7, 2020)
Aurelie de Rus Jacquet et al.
MOLECULAR PSYCHIATRY (2021)
Development of Polymer-Based Nanoformulations for Glioblastoma Brain Cancer Therapy and Diagnosis: An Update
Bijuli Rabha et al.
POLYMERS (2021)
Surface Functionalization of PLGA Nanoparticles to Increase Transport across the BBB for Alzheimer's Disease
Laura Del Amo et al.
APPLIED SCIENCES-BASEL (2021)
PLGA Nanoparticle-Based Formulations to Cross the Blood-Brain Barrier for Drug Delivery: From R&D to cGMP
Kaining Zhi et al.
PHARMACEUTICS (2021)
Blood-Brain Barrier and Neurodegenerative Diseases-Modeling with iPSC-Derived Brain Cells
Ying-Chieh Wu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
PLGA-PEG Nanoparticles Facilitate In Vivo Anti-Alzheimer's Effects of Fucoxanthin, a Marine Carotenoid Derived from Edible Brown Algae
Mengxiang Yang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2021)
Dopamine-loaded nanoparticle systems circumvent the blood-brain barrier restoring motor function in mouse model for Parkinson's Disease
Victoria Monge-Fuentes et al.
SCIENTIFIC REPORTS (2021)
Polyester Polymeric Nanoparticles as Platforms in the Development of Novel Nanomedicines for Cancer Treatment
Enrique Niza et al.
CANCERS (2021)
Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases
Priscila Baltazar Goncalves et al.
BIOMOLECULES (2021)
Prophylactic and Therapeutic Effects of MOG-Conjugated PLGA Nanoparticles in C57Bl/6 Mouse Model of Multiple Sclerosis
Mehrdad Gholamzad et al.
ADVANCED PHARMACEUTICAL BULLETIN (2021)
Blood-brain barrier dysfunction as a potential therapeutic target for neurodegenerative disorders
Ajay Uprety et al.
ARCHIVES OF PHARMACAL RESEARCH (2021)
Phytol loaded PLGA nanoparticles regulate the expression of Alzheimer's related genes and neuronal apoptosis against amyloid-β induced toxicity in Neuro-2a cells and transgenic Caenorhabditis elegans
Sethuraman Sathya et al.
FOOD AND CHEMICAL TOXICOLOGY (2020)
Rhynchophylline Loaded-mPEG-PLGA Nanoparticles Coated with Tween-80 for Preliminary Study in Alzheimer's Disease
Ruiling Xu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
In vitro and in vivo evaluation of levodopa-loaded nanoparticles for nose to brain delivery
Sema Arisoy et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2020)
The Design of Poly(lactide-co-glycolide) Nanocarriers for Medical Applications
Divesha Essa et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
A Conditionally Releasable Do not Eat Me CD47 Signal Facilitates Microglia-Targeted Drug Delivery for the Treatment of Alzheimer's Disease
Lun Zhang et al.
ADVANCED FUNCTIONAL MATERIALS (2020)
The blood-brain barrier in health and disease: Important unanswered questions
Caterina P. Profaci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer's disease
Chunhong Gao et al.
JOURNAL OF NANOBIOTECHNOLOGY (2020)
Stealth Coating of Nanoparticles in Drug-Delivery Systems
See Yee Fam et al.
NANOMATERIALS (2020)
Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders
Salman Ul Islam et al.
MOLECULES (2020)
In vitro Models of Neurodegenerative Diseases
Anna Slanzi et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Intravenously Administered, Retinoid Activating Nanoparticles Increase Lifespan and Reduce Neurodegeneration in the SOD1G93A Mouse Model of ALS
David X. Medina et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders
Eva Gil-Martins et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Treatment of Multiple Sclerosis: A Review
Stephen L. Hauser et al.
AMERICAN JOURNAL OF MEDICINE (2020)
Review of hybrid PLGA nanoparticles: Future of smart drug delivery and theranostics medicine
Jana Ghitman et al.
MATERIALS & DESIGN (2020)
Epigallocatechin-3-gallate PEGylated poly(lactic-co-glycolic) acid nanoparticles mitigate striatal pathology and motor deficits in 3-nitropropionic acid intoxicated mice
Amanda Cano et al.
NANOMEDICINE (2020)
Sustained in vitro interferon-beta release and in vivo toxicity of PLGA and PEG-PLGA nanoparticles
Andrea Fodor-Kardos et al.
RSC ADVANCES (2020)
2020 Alzheimer's disease facts and figures
[Anonymous]
ALZHEIMERS & DEMENTIA (2020)
Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs
Manoj Kumar Jaiswal
MEDICINAL RESEARCH REVIEWS (2019)
Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology
Rui Pedro Moura et al.
EXPERT OPINION ON DRUG DELIVERY (2019)
Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments
Thais A. Sales et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
Amanda Cano et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Vitamin D-binding protein-loaded PLGA nanoparticles suppress Alzheimer's disease-related pathology in 5XFAD mice
Seong Gak Jeon et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Excess glutamate secreted from astrocytes drives upregulation of P-glycoprotein in endothelial cells in amyotrophic lateral sclerosis
Loqman A. Mohamed et al.
EXPERIMENTAL NEUROLOGY (2019)
Biodegradable PLGA Nanoparticles Restore Lysosomal Acidity and Protect Neural PC-12 Cells against Mitochondrial Toxicity
Jialiu Zeng et al.
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH (2019)
Ageing as a risk factor for neurodegenerative disease
Yujun Hou et al.
NATURE REVIEWS NEUROLOGY (2019)
Nanoparticles Mediating the Sustained Puerarin Release Facilitate Improved Brain Delivery to Treat Parkinson's Disease
Tongkai Chen et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Biodegradable Nanoparticles Containing Mechanism Based Peptide Inhibitors Reduce Polyglutamine Aggregation in Cell Models and Alleviate Motor Symptoms in a Drosophila Model of Huntington's Disease
Abhayraj S. Joshi et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Hazard Assessment of Polymeric Nanobiomaterials for Drug Delivery: What Can We Learn From Literature So Far
Sandra Jesus et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2019)
A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid beta aggregation in Alzheimer's disease
Xinlong Huo et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2019)
Cationic carrier peptide enhances cerebrovascular targeting of nanoparticles in Alzheimer's disease brain
Kristen M. Ahlschwede et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
A window into the brain: Tools to assess pre-clinical efficacy of biomaterials-based therapies on central nervous system disorders
Juhi Samal et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Nanoparticles in the clinic: An update
Aaron C. Anselmo et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2019)
Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson's disease
Shengnan Tang et al.
DRUG DELIVERY (2019)
In Vitro Microfluidic Models for Neurodegenerative Disorders
Tatsuya Osaki et al.
ADVANCED HEALTHCARE MATERIALS (2018)
Targeted Brain Delivery of Rabies Virus Glycoprotein 29-Modified Deferoxamine-Loaded Nanoparticles Reverses Functional Deficits in Parkinsonian Mice
Linhao You et al.
ACS NANO (2018)
Customizing poly(lactic-co-glycolic acid) particles for biomedical applications
Edyta Swider et al.
ACTA BIOMATERIALIA (2018)
Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics
Yijun Pan et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Lactoferrin functionalized PEG-PLGA nanoparticles of shikonin for brain targeting therapy of glioma
Hanmei Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease
Qingqing Meng et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery
Antonietta Vilella et al.
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2018)
Nanoparticle crossing of blood-brain barrier: a road to new therapeutic approaches to central nervous system diseases
Valentin Cena et al.
NANOMEDICINE (2018)
Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Melanie D. Sweeney et al.
NATURE REVIEWS NEUROLOGY (2018)
Multiple Sclerosis: Mechanisms and Immunotherapy
Clare Baecher-Allan et al.
NEURON (2018)
Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease
Marissa Dean et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization
Elena Sanchez-Lopez et al.
JOURNAL OF NANOBIOTECHNOLOGY (2018)
Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting
Fabio Sonvico et al.
PHARMACEUTICS (2018)
Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer's disease
Shengnuo Fan et al.
DRUG DELIVERY (2018)
PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer's disease: in vitro and in vivo studies
Marcelle Silva-Abreu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Treatment of neurodegenerative disorders through the blood-brain barrier using nanocarriers
N. Poovaiah et al.
NANOSCALE (2018)
Selective vulnerability in neurodegenerative diseases
Hongjun Fu et al.
NATURE NEUROSCIENCE (2018)
Animal models of neurodegenerative diseases
Ted M. Dawson et al.
NATURE NEUROSCIENCE (2018)
Nano based drug delivery systems: recent developments and future prospects
Jayanta Kumar Patra et al.
JOURNAL OF NANOBIOTECHNOLOGY (2018)
Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa
Stella Gaenger et al.
PHARMACEUTICS (2018)
All (animal) models (of neurodegeneration) are wrong. Are they also useful?
Richard M. Ransohoff
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Inhibitory Effects of Commonly Used Excipients on P-Glycoprotein in Vitro
Rohan Gurjar et al.
MOLECULAR PHARMACEUTICS (2018)
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference
Alexandra L. Young et al.
NATURE COMMUNICATIONS (2018)
PLGA-Based Nanoparticles in Cancer Treatment
Sima Rezvantalab et al.
FRONTIERS IN PHARMACOLOGY (2018)
Phenotypic Heterogeneity in Dementia: A Challenge for Epidemiology and Biomarker Studies
Joanne Ryan et al.
FRONTIERS IN PUBLIC HEALTH (2018)
Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures
Heloise Ragelle et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
Recent advances in aliphatic polyesters for drug delivery applications
Katherine E. Washington et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2017)
Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue
Xuemei Zhang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Rasagiline-encapsulated chitosan-coated PLGA nanoparticles targeted to the brain in the treatment of parkinson's disease
Niyaz Ahmad
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES (2017)
Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood-Brain Barrier
Ilaria Monaco et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Polymeric nanoparticles: A study on the preparation variables and characterization methods
Carina I. C. Crucho et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2017)
Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP
Mariline Gameiro et al.
MOLECULES (2017)
Delivery of siRNA silencing P-gp in peptide-functionalized nanoparticles causes efflux modulation at the blood-brain barrier
Maria Joao Gomes et al.
NANOMEDICINE (2017)
New potential strategies for Alzheimer's disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe/PS1dE9
Elena Sanchez-Lopez et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes
Valentin K. Gribkoff et al.
NEUROPHARMACOLOGY (2017)
PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering Aβ generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer's disease mice
Na Huang et al.
ONCOTARGET (2017)
Ascorbic acid tethered polymeric nanoparticles enable efficient brain delivery of galantamine: An in vitro-in vivo study
Kavita R. Gajbhiye et al.
SCIENTIFIC REPORTS (2017)
Recent applications of PLGA based nanostructures in drug delivery
Maria Mir et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2017)
Nanotechnology-based drug delivery of ropinirole for Parkinson's disease
Emilia Barcia et al.
DRUG DELIVERY (2017)
Small-Sized mPEG PLGA Nanoparticles of Schisantherin A with Sustained Release for Enhanced Brain Uptake and Anti-Parkinsonian Activity
Tongkai Chen et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
T7 Peptide-Functionalized PEG-PLGA Micelles Loaded with Carmustine for Targeting Therapy of Glioma
Yunke Bi et al.
ACS APPLIED MATERIALS & INTERFACES (2016)
Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases
Mathieu Bourdenx et al.
AUTOPHAGY (2016)
Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatment
Joana A. Loureiro et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer's disease
Dongdong Sun et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier
David S. Hersh et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
ABC transporters at the blood-brain barrier
Anne Mahringer et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment
Chenchen Bi et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
MicroRNA-124 loaded nanoparticles enhance brain repair in Parkinson's disease
C. Saraiva et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases
Claudia Saraiva et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Pericytes of the neurovascular unit: key functions and signaling pathways
Melanie D. Sweeney et al.
NATURE NEUROSCIENCE (2016)
Progress and perspectives on targeting nanoparticles for brain drug delivery
Huile Gao
ACTA PHARMACEUTICA SINICA B (2016)
Choline Derivate-Modified Doxorubicin Loaded Micelle for Glioma Therapy
Jianfeng Li et al.
ACS APPLIED MATERIALS & INTERFACES (2015)
Trans-Blood Brain Barrier Delivery of Dopamine-Loaded Nanoparticles Reverses Functional Deficits in Parkinsonian Rats
Richa Pahuja et al.
ACS NANO (2015)
Cerebrovascular and blood-brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology
Janelle Drouin-Ouellet et al.
ANNALS OF NEUROLOGY (2015)
Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF)
Sonja Rittchen et al.
BIOMATERIALS (2015)
Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders
Hisham Qosa et al.
BRAIN RESEARCH (2015)
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice
Marta Valenza et al.
EMBO MOLECULAR MEDICINE (2015)
What is the future of PEGylated therapies?
Magdalena Swierczewska et al.
EXPERT OPINION ON EMERGING DRUGS (2015)
Control of polymeric nanoparticle size to improve therapeutic delivery
John W. Hickey et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Systemic delivery of blood-brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissue
Jennifer K. Saucier-Sawyer et al.
JOURNAL OF DRUG TARGETING (2015)
Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
Renata Silva et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis
Gennaro Pagano et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Precision Nanomedicine in Neurodegenerative Diseases
Meir Goldsmith et al.
ACS NANO (2014)
A Biodegradable Nanoparticle Platform for the Induction of Antigen-Specific Immune Tolerance for Treatment of Autoimmune Disease
Zoe Hunter et al.
ACS NANO (2014)
Role of the Blood-Brain Barrier in Multiple Sclerosis
Genaro Gabriel Ortiz et al.
ARCHIVES OF MEDICAL RESEARCH (2014)
Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer's disease mice
Chi Zhang et al.
BIOMATERIALS (2014)
Retinoic acid signaling pathways in development and diseases
Bhaskar C. Das et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Molecular Effects of L-dopa Therapy in Parkinson's Disease
Jolanta Dorszewska et al.
CURRENT GENOMICS (2014)
Nanotechnology and Antioxidant Therapy: An Emerging Approach for Neurodegenerative Diseases
Carlos Fernandes et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting
Bhavna et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2014)
Surfactants, not size or zeta-potential influence blood-brain barrier passage of polymeric nanoparticles
[Anonymous]
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
Cell- Based in Vitro Blood-Brain Barrier Model Can Rapidly Evaluate Nanoparticles' Brain Permeability in Association with Particle Size and Surface Modification
Sanshiro Hanada et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer's disease
Chi Zhang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
PEG - A versatile conjugating ligand for drugs and drug delivery systems
Atul Kolate et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies
Joana A. Loureiro et al.
NANOMEDICINE (2014)
Polymeric nanocarriers for expected nanomedicine: current challenges and future prospects
B. Daglar et al.
RSC ADVANCES (2014)
Inhibiting drug efflux transporters improves efficacy of ALS therapeutics
Michael R. Jablonski et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Increasing the Efficiency of Parkinson's Disease Treatment Using a poly(lactic-co-glycolic acid) (PLGA) Based L-DOPA Delivery System
P.Y. Gambaryan et al.
Experimental Neurobiology (2014)
B6 Peptide-Modified PEG-PLA Nanoparticles for Enhanced Brain Delivery of Neuroprotective Peptide
Zhongyang Liu et al.
BIOCONJUGATE CHEMISTRY (2013)
Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles
Yung-Chih Kuo et al.
BIOMATERIALS (2013)
N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
David Olivares et al.
Current Alzheimer Research (2013)
Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting
Chandrakantsing Vijaysing Pardeshi et al.
EXPERT OPINION ON DRUG DELIVERY (2013)
Nicotine-encapsulated poly(lactic-co-glycolic) acid nanoparticles improve neuroprotective efficacy against MPTP-induced parkinsonism
Manindra Nath Tiwari et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Optimization of brain targeted chitosan nanoparticles of Rivastigmine for improved efficacy and safety
Kalpana Nagpal et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2013)
The current and projected economic burden of Parkinson's disease in the United States
Stacey L. Kowal et al.
MOVEMENT DISORDERS (2013)
Brain Delivery of NAP with PEG-PLGA Nanoparticles Modified with Phage Display Peptides
Jingwei Li et al.
PHARMACEUTICAL RESEARCH (2013)
Current drug research on PEGylation with small molecular agents
Wenjun Li et al.
PROGRESS IN POLYMER SCIENCE (2013)
PLA/PLGA nanoparticles for delivery of drugs across the blood-brain barrier
Jingyan Li et al.
NANOTECHNOLOGY REVIEWS (2013)
Current and future treatments for Alzheimer's disease
Konstantina G. Yiannopoulou et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2013)
Modern methods for delivery of drugs across the blood-brain barrier
Yan Chen et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Real-time analysis of P-glycoprotein-mediated drug transport across primary intestinal epithelium three-dimensionally cultured in vitro
Tomohiro Mizutani et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles
Hongliang Xin et al.
BIOMATERIALS (2012)
Role of Catechol-O-Methyltransferase (COMT)-Dependent Processes in Parkinson's Disease and L-DOPA Treatment
Stefano Espinoza et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2012)
Transcytosis of CRM197-grafted polybutylcyanoacrylate nanoparticles for delivering zidovudine across human brain-microvascular endothelial cells
Yung-Chih Kuo et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2012)
PLGA-based nanoparticles: An overview of biomedical applications
Fabienne Danhier et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging
Suphiya Parveen et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS
Michael R. Jablonski et al.
NEUROBIOLOGY OF DISEASE (2012)
Focused ultrasound disruption of the blood-brain barrier: a new frontier for therapeutic delivery in molecular neurooncology
Arnold B. Etame et al.
NEUROSURGICAL FOCUS (2012)
Self-Assembled Polymersomes Conjugated with Lactoferrin as Novel Drug Carrier for Brain Delivery
Yuan Yu et al.
PHARMACEUTICAL RESEARCH (2012)
Structure and Composition of Pulmonary Arteries, Capillaries, and Veins
Mary I. Townsley
COMPREHENSIVE PHYSIOLOGY (2012)
Micelle-Based Brain-Targeted Drug Delivery Enabled by a Nicotine Acetylcholine Receptor Ligand
Changyou Zhan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery
Jianwei Guo et al.
BIOMATERIALS (2011)
Amyotrophic lateral sclerosis: A neurovascular disease
Svitlana Garbuzova-Davis et al.
BRAIN RESEARCH (2011)
Blood-Brain Barrier P-Glycoprotein Function in Neurodegenerative Disease
A. L. Bartels
CURRENT PHARMACEUTICAL DESIGN (2011)
Extracellular Matrix and Matrix Receptors in Blood-Brain Barrier Formation and Stroke
Kim M. Baeten et al.
DEVELOPMENTAL NEUROBIOLOGY (2011)
The P-glycoprotein multidrug transporter
Frances J. Sharom
ESSAYS IN BIOCHEMISTRY: ABC TRANSPORTERS (2011)
Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(γ-glutamic acid)
Yung-Chih Kuo et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: Preparation, characterization and efficacy in Parkinson's disease
Kaili Hu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems-A review
Susanne Fredenberg et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
The Role of the Blood Brain Barrier in Neurodegenerative Disorders and their Treatment
Alan M. Palmer
JOURNAL OF ALZHEIMERS DISEASE (2011)
Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology
G. Mittal et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Odorranalectin-conjugated nanoparticles: Preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration
Ziyi Wen et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Targeting the insulin receptor: nanoparticles for drug delivery across the blood-brain barrier (BBB)
Karsten Ulbrich et al.
JOURNAL OF DRUG TARGETING (2011)
Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers
Werner Geldenhuys et al.
JOURNAL OF DRUG TARGETING (2011)
Biomedical Applications of Biodegradable Polymers
Bret D. Ulery et al.
JOURNAL OF POLYMER SCIENCE PART B-POLYMER PHYSICS (2011)
Cellular toxicity of inorganic nanoparticles: Common aspects and guidelines for improved nanotoxicity evaluation
Stefaan J. Soenen et al.
NANO TODAY (2011)
Nanoparticle PEGylation for imaging and therapy
Jesse V. Jokerst et al.
NANOMEDICINE (2011)
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Hirenkumar K. Makadia et al.
POLYMERS (2011)
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Katrin Knop et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
A leptin derived 30-amino-acid peptide modified pegylated poly-L-lysine dendrigraft for brain targeted gene delivery
Yang Liu et al.
BIOMATERIALS (2010)
Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain
Zhao H. Wang et al.
BIOMATERIALS (2010)
The application of mucoadhesive polymers in nasal drug delivery
Lingmin Jiang et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2010)
Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain
Tapan Parikh et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: Influence of the formulation parameters
Svetlana Gelperina et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: Importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug
Beom Suk Lee et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Brain-targeted delivery of Tempol-loaded nanoparticles for neurological disorders
Richard T. Carroll et al.
JOURNAL OF DRUG TARGETING (2010)
Structure and function of the blood-brain barrier
N. Joan Abbott et al.
NEUROBIOLOGY OF DISEASE (2010)
Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging
Sonu Bhaskar et al.
PARTICLE AND FIBRE TOXICOLOGY (2010)
The blood-brain barrier in brain homeostasis and neurological diseases
Nicolas Weiss et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2009)
The potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrier
Eugen Barbu et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles
Kamila B. Kurakhmaeva et al.
JOURNAL OF DRUG TARGETING (2009)
The blood-brain barrier in neurodegenerative disease: a rhetorical perspective
Paul M. Carvey et al.
JOURNAL OF NEUROCHEMISTRY (2009)
ABCG2 Is Upregulated in Alzheimer's Brain with Cerebral Amyloid Angiopathy and May Act as a Gatekeeper at the Blood-Brain Barrier for Aβ1-40 Peptides
Huaqi Xiong et al.
JOURNAL OF NEUROSCIENCE (2009)
Role of dopamine receptor agonists in the treatment of early Parkinson's disease
Ubaldo Bonuccelli et al.
PARKINSONISM & RELATED DISORDERS (2009)
Physiology and Function of the Tight Junction
James M. Anderson et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
CNS Delivery Via Adsorptive Transcytosis
Francoise Herve et al.
AAPS JOURNAL (2008)
Disulfide bridge based PEGylation of proteins
Steve Brocchini et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Multiple sclerosis: An immune or neurodegenerative disorder?
Bruce D. Trapp et al.
ANNUAL REVIEW OF NEUROSCIENCE (2008)
TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs
Kavitha S. Rao et al.
BIOMATERIALS (2008)
Biodistribution of colloidal gold nanoparticles after intravenous administration: Effect of particle size
Ganeshchandra Sonavane et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2008)
Mechanism of nanocapsules formation by the emulsion-diffusion process
Delphine Moinard-Checot et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2008)
Potential of solid lipid nanoparticles in brain targeting
Indu Pal Kaur et al.
JOURNAL OF CONTROLLED RELEASE (2008)
The origins and evolution of controlled drug delivery systems
Allan S. Hoffman
JOURNAL OF CONTROLLED RELEASE (2008)
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Frank Alexis et al.
MOLECULAR PHARMACEUTICS (2008)
Dexibuprofen (S(+)-isomer ibuprofen) reduces microglial activation and impairments of spatial working memory induced by chronic lipopolysaccharide infusion
Da-Qing Jin et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Distribution and potential toxicity of engineered inorganic nanoparticles and carbon nanostructures in biological systems
Eudald Casals et al.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2008)
Rivastigmine in the treatment of Alzheimer's disease: an update
Maria Luisa Onor et al.
CLINICAL INTERVENTIONS IN AGING (2007)
Blood-brain barrier delivery
William M. Pardridge
DRUG DISCOVERY TODAY (2007)
Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies
Q Shen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Epidemiology of Parkinson's disease
Lonneke M. L. de Lau et al.
LANCET NEUROLOGY (2006)
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier
L Costantino et al.
JOURNAL OF CONTROLLED RELEASE (2005)
The genetic epidemidogy of neurodegenerative disease
L Bertram et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
The blood-brain barrier/neurovascular unit in health and disease
BT Hawkins et al.
PHARMACOLOGICAL REVIEWS (2005)
Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases
W Löscher et al.
PROGRESS IN NEUROBIOLOGY (2005)
Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense
EM Leslie et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
Drug delivery systems: Entering the mainstream
TM Allen et al.
SCIENCE (2004)
Importance of P-glycoprotein at blood-tissue barriers
MF Fromm
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
ABC transporters and the blood-brain barrier
DJ Begley
CURRENT PHARMACEUTICAL DESIGN (2004)
Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo
G Cornaire et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Nanoparticle surface charges alter blood-brain barrier integrity and permeability
PR Lockman et al.
JOURNAL OF DRUG TARGETING (2004)
Commonly used surfactant, tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats
HJ Zhang et al.
ARCHIVES OF PHARMACAL RESEARCH (2003)
Blood-brain barrier disruption in multiple sclerosis
A Minagar et al.
MULTIPLE SCLEROSIS JOURNAL (2003)
A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro
ED Hugger et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier
Y Gilgun-Sherki et al.
NEUROPHARMACOLOGY (2001)
Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C
A Kozlowski et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Apoptosis in neurodegenerative disorders
MP Mattson
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2000)
Osmotic opening of the blood-brain barrier: Principles, mechanism, and therapeutic applications
SI Rapoport
CELLULAR AND MOLECULAR NEUROBIOLOGY (2000)
In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams
L Lu et al.
BIOMATERIALS (2000)
Share Paper
